Lilly and T1D Exchange Diabetes Research Collaboration

Disclosed Personal Data Health


In 2014, Unito's diabetes research program T1D Exchange and healthcare provider Eli Lilly and Company announced a collaboration: The Lily and T1D Exchange Diabetes Research Collaboration. The Exchange acts as a convener of clinicians, patients and caregivers working to improve the health outcomes of patients with Type 1 Diabetes. By connecting these people to one another and to the patient community at large, T1D Exchange aims to be the translational engine that enables the entire T1D ecosystem to collaborate via a Clinic Network, Clinic Registry, Sample Repository, and the online patient/caregiver community, Glu. Though it is unclear where the collaborative now stands, the initial premise was to analyze T1D exchange data and develop a survey for health care providers from the clinic network and members of Glu, and online patient and caregiver platform. Following the survey, further surveys were to be undertaken and shared with patients to collect data. The data is to be shared publicly once analysis is complete, for the benefit of both the Type 1 diabetes and researcher communities.

Region: North America

includes kosovo